- Home
- ALGS vs ACFN Comparison
ALGS vs ACFN Comparison
Compare ALGS & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- ACFN
- Stock Information
- Founded
- ALGS 2018
- ACFN 1986
- Country
- ALGS United States
- ACFN United States
- Employees
- ALGS N/A
- ACFN N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- ACFN Military/Government/Technical
- Sector
- ALGS Health Care
- ACFN Consumer Discretionary
- Exchange
- ALGS Nasdaq
- ACFN Nasdaq
- Market Cap
- ALGS 53.0M
- ACFN 44.7M
- IPO Year
- ALGS 2020
- ACFN N/A
- Fundamental
- Price
- ALGS $7.70
- ACFN $25.16
- Analyst Decision
- ALGS Strong Buy
- ACFN
- Analyst Count
- ALGS 1
- ACFN 0
- Target Price
- ALGS $70.00
- ACFN N/A
- AVG Volume (30 Days)
- ALGS 62.6K
- ACFN 54.0K
- Earning Date
- ALGS 08-06-2025
- ACFN 08-07-2025
- Dividend Yield
- ALGS N/A
- ACFN N/A
- EPS Growth
- ALGS N/A
- ACFN 1520.82
- EPS
- ALGS N/A
- ACFN 2.84
- Revenue
- ALGS $3,174,000.00
- ACFN $13,202,000.00
- Revenue This Year
- ALGS N/A
- ACFN N/A
- Revenue Next Year
- ALGS $51.55
- ACFN N/A
- P/E Ratio
- ALGS N/A
- ACFN $8.87
- Revenue Growth
- ALGS N/A
- ACFN 50.98
- 52 Week Low
- ALGS $3.76
- ACFN $17.22
- 52 Week High
- ALGS $46.80
- ACFN $33.00
- Technical
- Relative Strength Index (RSI)
- ALGS 46.70
- ACFN N/A
- Support Level
- ALGS $7.31
- ACFN N/A
- Resistance Level
- ALGS $7.85
- ACFN N/A
- Average True Range (ATR)
- ALGS 0.75
- ACFN 0.00
- MACD
- ALGS -0.09
- ACFN 0.00
- Stochastic Oscillator
- ALGS 35.03
- ACFN 0.00
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.